Japanese company reviewing new mid-stage clinical findings for novel regeneration-inducing drug in dystrophic epidermolysis bullosa and acute ischemic stroke.
Japanese company reviewing new mid-stage clinical findings for novel regeneration-inducing drug in dystrophic epidermolysis bullosa and acute ischemic stroke.